intES

Japan · Biotech

intES develops embryonic stem cell-based tissue for regenerative medicine.

Product

intES is developing intestinal tissue sheets derived from embryonic stem cells for inflammatory bowel disease. Its research aims to regenerate damaged intestinal mucosa through transplantation of the engineered tissue.

The startup is working toward scalable tissue production, drawing on experience in cell manufacturing, safety assessment and regulatory processes. Akihiro Umezawa serves as its technical adviser.

Funding history

1 round · 0 with disclosed amounts
AnnouncedRoundAmountInvestors
1stRound non-equity supportUndisclosedUTokyo Innovation Platform Co — Participant
Sourcesutokyo-ipc.co.jp ↗